William Edward McKechnie - 29 Jul 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/William McKechnie/
Issuer symbol
LEXX
Transactions as of
29 Jul 2025
Net transactions value
+$4,532
Form type
4
Filing time
30 Jul 2025, 12:37:08 UTC
Previous filing
16 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McKechnie William Edward Director 235 WESTVALE DRIVE, WATERLOO, ONTARIO, CANADA /William McKechnie/ 30 Jul 2025 0001658613

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $4,532 +5,000 +38% $0.9063 18,191 29 Jul 2025 Direct
holding LEXX common shares 13,191 29 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 1,500 29 Jul 2025 Common Shares 1,500 $3.00 Direct
holding LEXX Stock Options 6,500 29 Jul 2025 Common Shares 5,000 $3.00 Direct
holding LEXX Stock Options 8,400 29 Jul 2025 Common Shares 1,900 $3.00 Direct
holding LEXX Stock Options 11,800 29 Jul 2025 Common Shares 3,400 $3.39 Direct
holding LEXX Stock Options 30,000 29 Jul 2025 Common Shares 18,200 $1.96 Direct
holding LEXX Stock Options 35,000 29 Jul 2025 Common Shares 5,000 $0.8700 Direct
holding LEXX Stock Options 40,000 29 Jul 2025 Common Shares 5,000 $2.36 Direct
holding LEXX Stock Options 52,000 29 Jul 2025 Common Shares 12,000 $3.39 Direct
holding LEXX Stock Options 63,000 29 Jul 2025 Common Shares 11,000 $1.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.